Related Materials - European Society of Cardiology

ESC/EACTS Page 30 of 34
eluting stents versus bare-metal stents in acute myocardial
infarction. N Engl J Med 2009;360(19):1946-1959.
Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T, Nakamura T,
Fujita S, Takeda S, Motohara S, Uehata H. Biodegradable stents as
a platform to drug loading. Int J Cardiovasc Intervent 2003;5(1):13-
16.
van der Hoeven BL, Liem SS, Jukema JW, Suraphakdee N, Putter H,
Dijkstra J, Atsma DE, Bootsma M, Zeppenfeld K, Oemrawsingh PV,
van der Wall EE, Schalij MJ. Sirolimus-eluting stents versus baremetal
stents in patients with ST-segment elevation myocardial
infarction: 9-month angiographic and intravascular ultrasound
results and 12-month clinical outcome results from the MISSION!
Intervention Study. J Am Coll Cardiol 2008;51:618-626.
Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens
C, Bruining N, van den Branden F, Van LG. Randomized doubleblind
comparison of sirolimus-eluting stent versus bare-metal
stent implantation in diseased saphenous vein grafts: six-month
angiographic, intravascular ultrasound, and clinical follow-up of
the RRISC Trial. J Am Coll Cardiol 2006;48(12):2423-2431.
Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens
C, van den Branden F, Van LG. Increased late mortality after
sirolimus-eluting stents versus bare-metal stents in diseased
saphenous vein grafts: results from the randomized DELAYED
RRISC Trial. J Am Coll Cardiol 2007;50(3):261-267.
Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I,
Ghini AS, Ferrero V, Chiariello L, Gioffre PA, Romeo F, Crea F.
Immunosuppressive Therapy for the Prevention of Restenosis
after Coronary Artery Stent Implantation (IMPRESS Study). J Am
Coll Cardiol 2002;40(11):1935-1942.
Waksman R, Ajani AE, Pichard AD, Torguson R, Pinnow E, Canos
D, Satler LF, Kent KM, Kuchulakanti P, Pappas C, Gambone L,
Weissman N, Abbott MC, Lindsay J. Oral rapamycin to inhibit
restenosis after stenting of de novo coronary lesions: the Oral
Rapamune to Inhibit Restenosis (ORBIT) study. J Am Coll Cardiol
2004;44(7):1386-1392.
11.4 Adjunctive invasive diagnostic tools
Bech GJ, de BB, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J,
Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W. Fractional
flow reserve to determine the appropriateness of angioplasty
in moderate coronary stenosis: a randomized trial. Circulation
2001;103(24):2928-2934.
Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J,
Heyndrickx GR, Pijls NH, de BB. Long-term clinical outcome
after fractional flow reserve-guided percutaneous coronary
intervention in patients with multivessel disease. J Am Coll Cardiol
2005;46(3):438-442.
Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI.
Intracoronary optical coherence tomography: a comprehensive
review clinical and research applications. JACC Cardiovasc Interv
2009;2(11):1035-1046.
De Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrickx GR,
Wijns W. Simultaneous coronary pressure and flow velocity
measurements in humans. Feasibility, reproducibility, and
hemodynamic dependence of coronary flow velocity reserve,
hyperemic flow versus pressure slope index, and fractional flow
reserve. Circulation 1996;94(8):1842-1849.
De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De WH, Van
CP, Heyndrickx GR, Wijns W. Fractional flow reserve in patients
with prior myocardial infarction. Circulation 2001;104(2):157-162.
Fischer JJ, Samady H, McPherson JA, Sarembock IJ, Powers ER,
Gimple LW, Ragosta M. Comparison between visual assessment
and quantitative angiography versus fractional flow reserve for
native coronary narrowings of moderate severity. Am J Cardiol
2002;90(3):210-215.
Fitzgerald PJ, Oshima A, Hayase M, Metz JA, Bailey SR, Baim DS,
Cleman MW, Deutsch E, Diver DJ, Leon MB, Moses JW, Oesterle
SN, Overlie PA, Pepine CJ, Safian RD, Shani J, Simonton CA,
Smalling RW, Teirstein PS, Zidar JP, Yeung AC, Kuntz RE, Yock
PG. Final results of the Can Routine Ultrasound Influence Stent
Expansion (CRUISE) study. Circulation 2000;102(5):523-530.
Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno
G, Nelis O, Bartunek J, Vanderheyden M, Wyffels E, Barbato E,
Heyndrickx GR, Wijns W, de BB. Long-term clinical outcome
after fractional flow reserve-guided treatment in patients with
angiographically equivocal left main coronary artery stenosis.
Circulation 2009;120(15):1505-1512.
Hong MK, Mintz GS, Lee CW, Park DW, Choi BR, Park KH, Kim
YH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Intravascular
ultrasound predictors of angiographic restenosis after sirolimuseluting
stent implantation. Eur Heart J 2006;27(11):1305-1310.
Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF.
Frequency of stress testing to document ischemia prior to elective
percutaneous coronary intervention. JAMA 2008;300(15):1765-
1773.
Lopez-Palop R, Pinar E, Lozano I, Saura D, Pico F, Valdes M. Utility
of the fractional flow reserve in the evaluation of angiographically
moderate in-stent restenosis. Eur Heart J 2004;25(22):2040-
2047.
Manoharan G, Ntalianis A, Muller O, Hamilos M, Sarno G, Melikian
N, Vanderheyden M, Heyndrickx GR, Wyffels E, Wijns W, de
BB. Severity of coronary arterial stenoses responsible for acute
coronary syndromes. Am J Cardiol 2009;103(9):1183-1188.
Melikian N, De BP, Tonino P, De WO, Wyffels E, Bartunek J,
Heyndrickx GR, Fearon WF, Pijls NH, Wijns W, de BB. Fractional
flow reserve and myocardial perfusion imaging in patients
with angiographic multivessel coronary artery disease. JACC
Cardiovasc Interv 2010;3(3):307-314.
Mudra H, Di MC, de JP, Figulla HR, Macaya C, Zahn R, Wennerblom B,
Rutsch W, Voudris V, Regar E, Henneke KH, Schachinger V, Zeiher
A. Randomized comparison of coronary stent implantation under
ultrasound or angiographic guidance to reduce stent restenosis
(OPTICUS Study). Circulation 2001;104(12):1343-1349.
Orford JL, Lerman A, Holmes DR. Routine intravascular ultrasound
guidance of percutaneous coronary intervention: a critical
reappraisal. J Am Coll Cardiol 2004;43(8):1335-1342.
Pijls NH, de BB, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek
JKJ, Koolen JJ. Measurement of fractional flow reserve to assess
the functional severity of coronary-artery stenoses. N Engl J Med
1996;334(26):1703-1708.
Prati F, Regar E, Mintz GS, Arbustini E, Di MC, Jang IK, Akasaka T,
Costa M, Guagliumi G, Grube E, Ozaki Y, Pinto F, Serruys PW.
Expert review document on methodology, terminology, and clinical
applications of optical coherence tomography: physical principles,
methodology of image acquisition, and clinical application for
assessment of coronary arteries and atherosclerosis. Eur Heart
J 2010;31:401-415.
Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL,
Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard
AD, Weissman NJ, Lindsay J, Waksman R. The potential clinical
utility of intravascular ultrasound guidance in patients undergoing
percutaneous coronary intervention with drug-eluting stents. Eur
Heart J 2008;29(15):1851-1857.
Schiele F, Meneveau N, Vuillemenot A, Zhang DD, Gupta S, Mercier
M, Danchin N, Bertrand B, Bassand JP. Impact of intravascular
ultrasound guidance in stent deployment on 6-month restenosis
rate: a multicenter, randomized study comparing two strategies-with
and without intravascular ultrasound guidance. RESIST Study
Group. REStenosis after Ivus guided STenting. J Am Coll Cardiol